| Patents for A61P 23 - Anaesthetics (4,141) |
|---|
| 10/10/2002 | WO2002078705A1 Hsp inductor |
| 10/09/2002 | EP1246793A2 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 10/09/2002 | EP1246791A2 Aminomethyl-phenyl-cyclohexanone derivatives |
| 10/09/2002 | EP1246625A2 Methods and compositions for mitigating pain using nitrate esters |
| 10/09/2002 | EP0914107B1 Compositions comprising lidocaine and emu oil and methods of use thereof |
| 10/03/2002 | WO2002076444A1 Molecular neurochirurgerie for pain control administering locally capsaicin or resiniferatoxin |
| 10/03/2002 | WO2001064187A8 Anaesthetic formulations |
| 10/02/2002 | EP1244616A1 (hetero)bicyclylmethanesulfonylamino-substituted hydroxamic acid derivatives |
| 10/02/2002 | EP1244498A2 Combination of trimebutine with an opioid analgesic |
| 10/02/2002 | EP1244401A1 Drug delivery of phase changing formulation |
| 10/02/2002 | DE10112825A1 HESylierung von Wirkstoffen in wässriger Lösung HESylation of drugs in aqueous solution |
| 10/01/2002 | CA2106312C Percutaneous anaesthesia |
| 09/26/2002 | WO2002074297A1 Novel use of a peptide class of compound for treating allodynia or other different types of chronic or phantom pain |
| 09/26/2002 | WO2002074200A1 Formulations containing propofol and a sulfoalkyl ether cyclodextrin |
| 09/25/2002 | EP1243263A1 Novel use of a peptide class of compound for treating allodynia or other different types of chronic or phantom pain |
| 09/25/2002 | EP1242410A1 Novel compounds |
| 09/25/2002 | EP1242406A1 Novel compounds |
| 09/25/2002 | EP1242396A1 New p2x 7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases |
| 09/19/2002 | WO2002072137A2 Anaesthetic formulation comprising articaine |
| 09/19/2002 | WO2001097779A3 Improved injectable dispersions of propofol |
| 09/18/2002 | EP1239845A2 Hydroxide-releasing agents as skin permeation enhancers |
| 09/17/2002 | US6451854 α-amino acid phenyl ester derivatives |
| 09/17/2002 | US6451848 Compositions and methods comprising morphine gluconate |
| 09/12/2002 | WO2002069930A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 09/12/2002 | US20020127249 Novel formulation for use in pain management |
| 09/12/2002 | US20020127235 Identification and molecular characterization of proteins, expressed in the Ixodes ricinus salivary glands |
| 09/12/2002 | US20020127198 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 09/12/2002 | CA2438326A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 09/11/2002 | EP1238677A2 Parenteral fat emulsions comprising edetate as preservative |
| 09/11/2002 | EP1237554A2 Use of sodium channel antagonists for the treatment of diseases related to apoptosis |
| 09/11/2002 | EP1047732B1 Color shifting film glitter |
| 09/06/2002 | WO2002067917A1 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 09/06/2002 | WO2002067903A2 Compositions and methods of manufacture for oral dissolvable dosage forms |
| 09/06/2002 | CA2439376A1 Compositions and methods of manufacture for oral dissolvable dosage forms |
| 09/06/2002 | CA2438784A1 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 09/04/2002 | EP1235827A2 Imidazo-pyridine derivatives as ligands for gaba receptors |
| 09/03/2002 | US6444859 Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid |
| 09/03/2002 | US6444647 Composition comprising safe and effective amounts of vitamin b3 compound and additional skin care active selected from farnesol and/or phytantriol, and dermatologically acceptable emulsion carrier |
| 08/29/2002 | WO2002066432A1 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof |
| 08/29/2002 | WO2001000247A9 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 08/29/2002 | US20020120002 2-tri-halo-1-methyl-N-acetyl-5-methoxytryptamine and a carrier |
| 08/29/2002 | US20020119186 Establishing a drug depot in tissues under the user's skin surface by applying a transdermal drug delivery system on a user's skin; allowing transdermal drug delivery system to be applied on skin area without heating; placing heating source |
| 08/29/2002 | DE10108307A1 Substituierte Propan-1,3-diamin-Derivate Substituted propane-1,3-diamine derivatives |
| 08/28/2002 | CN1089585C Use of levobupivacaine in facial surgery |
| 08/22/2002 | US20020114835 Administering at a site biocompatible, biodegradable, biodegradable, controlled release formulation comprising a local anesthetic, being present in a concentration effective to induce a localized condition |
| 08/20/2002 | US6436919 Local anesthetics that have longer duration of action while reducing undesired side effects |
| 08/15/2002 | WO2002062353A1 Composition containing sucrafate and a topical anesthetic for human and animals and method of use thereof |
| 08/15/2002 | WO2002000195A3 Methods and compositions for treating pain of the mucous membrane |
| 08/15/2002 | WO2001098265A3 Process for isolating enantiomers of racemic cetamine |
| 08/13/2002 | US6432401 Administering a local anesthetic and alpha adrenergic receptor agonist to induce local anesthesia followed by reversing anesthesia with a low dose of an alpha adrenergic receptor antagonist; use in hair graft procedures, for example |
| 08/07/2002 | EP1227714A1 Method for producing metabolites from plants cultivated in soil-less medium |
| 08/06/2002 | US6429228 Local anesthetic for external use |
| 08/01/2002 | WO2002058688A1 Use of neurotoxic substances in producing a medicament for treating joint pains |
| 08/01/2002 | WO2002058670A1 Local anesthetic, and method of use |
| 08/01/2002 | WO2001082914A3 Topical anesthetic/opioid formulations and uses thereof |
| 08/01/2002 | CA2435418A1 Use of neurotoxic substances in producing a medicament for treating joint pains |
| 07/30/2002 | US6426339 In situ; sustained release; preadministering glucocorticosteroid |
| 07/25/2002 | WO2002057218A1 Alanine 2,6-dialkoxyphenyl ester derivatives as hypnotics |
| 07/24/2002 | EP1224218A1 Dna encoding human alpha1g-c t-type calcium channel |
| 07/24/2002 | CN1360591A 3 alpha-hydroxy-3 beta-methoxymethyl-21-heterocycle substd. steroids with anesthetic activity |
| 07/24/2002 | CN1359677A Preparation of propofol with enhanced bacteria inhibition |
| 07/23/2002 | US6423725 Analgesics |
| 07/23/2002 | US6423338 Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |
| 07/18/2002 | WO2002055107A1 Topical anesthesia compositions |
| 07/17/2002 | EP1221939A1 Ortho ester lipids |
| 07/17/2002 | EP0842662B1 Percutaneous tape preparation containing fentanyl |
| 07/16/2002 | US6420390 Heteroarylpiperidines and their use as antipsychotics |
| 07/11/2002 | WO2000061231A3 Medical use |
| 07/10/2002 | EP1220690A2 Injection vehicle for polymer-based formulations |
| 07/10/2002 | EP1220657A1 Liposome encapsulated silver salt compositions |
| 07/04/2002 | WO2000076510A9 Dermal anesthetic agents |
| 07/04/2002 | US20020086405 56638, a novel human neprilysin protease and uses thereof |
| 07/03/2002 | EP1217975A1 Using quaternary ammonium salts for transdermal drug delivery |
| 07/03/2002 | EP1131062A4 Injectable propofol formulations |
| 07/03/2002 | CN1356987A Novel benzimidazole derivatives and pharmaceutical compsns. comprising these compounds |
| 07/03/2002 | CN1356896A Anesthetic compsn. for intravenous injection comprising propofol |
| 07/03/2002 | CN1356104A Antalgic method by general medicine application |
| 07/02/2002 | US6414011 Central nervous system disorders |
| 07/02/2002 | US6413987 Dermal anesthetic agents |
| 06/27/2002 | WO2002050057A1 Novel benzimidazole derivatives for the treatment of gaba-alpha mediated disorders |
| 06/27/2002 | WO2002049631A1 Propofol formulation with enhanced microbial inhibition |
| 06/27/2002 | CA2397990A1 Propofol formulation with enhanced microbial inhibition |
| 06/26/2002 | EP1216243A1 Quinazolinones and analogues and their use as local anesthetics |
| 06/26/2002 | EP1216242A1 Macrocyclic quinazolinones and their use as local anesthetics |
| 06/26/2002 | EP1216044A1 Compositions having improved stability |
| 06/26/2002 | EP1073414B1 Use of pharmaceutical compositions capable of being gelled in periodontology |
| 06/26/2002 | EP1049689B1 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists |
| 06/26/2002 | EP0998288B1 Compositions containing capsaicin or capsaicin analogues and a local anesthetic |
| 06/26/2002 | CN1355700A 皮肤麻醉剂 Skin anesthetic |
| 06/25/2002 | US6410790 Analgesics |
| 06/20/2002 | US20020076421 Oral liquid mucoadhesive compositions |
| 06/19/2002 | CN1086387C N-(aryloxyalkyl)heteroarylpiperidines and heteroarylpiperazines, their preparing method and their use as medicine |
| 06/18/2002 | US6407088 Method of analgesia |
| 06/18/2002 | CA2249375C Propofol microdroplet formulations |
| 06/13/2002 | WO2002045721A1 Noble gas complexes |
| 06/13/2002 | WO2002045709A1 Clear propofol compositions |
| 06/13/2002 | CA2432549A1 Clear propofol compositions |
| 06/12/2002 | EP1212058A1 Topical treatment for prevention of ocular infections |
| 06/12/2002 | EP1212052A2 Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate |
| 06/12/2002 | CN1353605A Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and use thereof |